3D Systems Gains FDA Clearance for VSP Orthopedics
ROCK HILL, S.C. – 3D Systems (NYSE: DDD) has exciting news for the medical community as it successfully obtained FDA 510(k) clearance. This significant milestone expands the indications for its VSP Orthopedics virtual surgical planning platform to include skeletally mature adolescents, alongside adults. This move not only enhances patient care but also offers opportunities for streamlined clinical practices and improved surgical outcomes.
Transforming Surgical Planning for Adolescents
With the new clearance, 3D Systems is facilitating a remarkable enhancement in how surgeries are planned and executed for young patients. By eliminating the need for individual compassionate-use approvals that were previously obligatory, this initiative simplifies processes for surgeons. It allows smoother transition of cases into standard treatments, enabling better access to innovative surgical methods for adolescents.
manual for surgical advantage
This change means that the thousands of adolescents facing orthopedic challenges, like those suffering from osteosarcoma and Ewing sarcoma, will have greater access to tailored surgical solutions. The annual rise in cases reveals a widening gap for effective treatments, thus positioning 3D Systems as a crucial player in addressing these needs.
Bridging Coverage Gaps
Favorable reimbursement scenarios are also on the horizon, as existing DRG/CPT codes now apply to these newly cleared procedures. 3D Systems can expect to convert off-label usage into fully reimbursable practices, ultimately bridging the gap in surgical care and enhancing the financial sustainability of hospitals.
Empowering Medical Professionals
Ben Johnson, senior vice president of medical technology at 3D Systems, remarked on the transformative potential of this clearance for the pediatric orthopedic oncology sector. He emphasized how this decision integrates previously used off-label solutions into routine practices, providing the much-needed support for adolescents affected by bone-related deformities.
The shift towards using FDA-cleared solutions promises to redefine the experience surrounding orthopedic interventions. This initiative not only expands treatment options but also assures parents and guardians that their children are receiving the best medical care available.
Financial Benefits and Sustainable Growth
With the new VSP indications, 3D Systems is expected to see a notable uptick in all its areas of service. The VSP Orthopedics platform generates revenue through a combination of fees for virtual planning, 3D-printed anatomical models, and tailored surgical guides. These elements contribute to the overall growth rates that have been trending positively for the company.
Moreover, the competitive edge that 3D Systems holds as the sole provider of FDA-cleared solutions for a variety of surgical needs strengthens its position within the medical technology landscape. The company has delivered over 400,000 patient-matched models and devices, showcasing its commitment to personalized healthcare solutions.
Commitment to Innovation
3D Systems has continuously focused on innovating and improving healthcare solutions. By working alongside healthcare professionals and leveraging advanced 3D printing technologies, the company has established itself as a leader in delivering personalized care. This commitment not only drives progress within the organization but also gradually transforms the landscape of healthcare as we know it.
About 3D Systems
For almost four decades, 3D Systems has been at the forefront of the 3D printing revolution, spearheaded by Chuck Hull, the visionary behind its inception. Today, 3D Systems continues to drive innovation in additive manufacturing across various sectors, including medical, aerospace, and consumer goods. The company’s dedication to working closely with clients ensures that they deliver effective, application-specific solutions aimed at enhancing their industries.
Frequently Asked Questions
What is the latest achievement of 3D Systems?
3D Systems has received FDA 510(k) clearance for its VSP Orthopedics platform, now including skeletally mature adolescents.
How does this approval benefit adolescent patients?
This approval enables easier access to tailored surgical solutions without the need for individual compassionate-use approvals.
What financial impacts can be expected from this clearance?
Increased revenue through procedures covered by existing codes and streamlined practices is anticipated, contributing to sustainable growth.
Who commented on the significance of this regulatory clearance?
Ben Johnson, senior vice president of medical technology, highlighted its transformative effect on pediatric orthopedic oncology practices.
How long has 3D Systems been in operation?
3D Systems has been innovating in the 3D printing industry for nearly 40 years, continuously evolving to meet industry needs.
